Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
brain cancer
Biotech
Telix shows 'promising’ 13-month OS in ph. 2 brain cancer study
Telix Pharmaceuticals has pointed to “promising efficacy” for its radiation therapy in a small study of patients with brain cancer.
James Waldron
Apr 16, 2025 6:30am
Jazz hands Chimerix $935M to buy near-approval cancer drug
Mar 5, 2025 8:13am
Merck snaps up preclinical DNA biotech for $1.3B biobucks
Oct 23, 2024 7:05am
Stryker strikes again, acquiring brain surgery devicemaker Nico
Sep 20, 2024 1:30pm
Kazia prunes failed cancer trial data set to form path to FDA
Jul 10, 2024 9:24am
mRNA vaccine for glioblastoma targets tumors in humans and dogs
May 7, 2024 5:30am
